Lombard Odier Asset Management (Switzerland)’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-337,617
Closed -$11.5M 316
2021
Q4
$11.5M Sell
337,617
-246,664
-42% -$9.66M 0.74% 51
2021
Q3
$28.2M Buy
584,281
+17,820
+3% +$825K 1.75% 11
2021
Q2
$25.6M Buy
566,461
+203,619
+56% +$9.02M 1.3% 24
2021
Q1
$17.5M Buy
+362,842
New +$18.9M 1.16% 30

Other funds holding NEO

Lombard Odier Asset Management (Switzerland)'s NEO Position: Q1 2022 in Review

Lombard Odier Asset Management (Switzerland) sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 337,617 shares — an estimated $11.5M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in NEO in Q1 2021 and held it in 4 quarters. The position peaked at $28.2M in Q3 2021. 280 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Lombard Odier Asset Management (Switzerland) reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 337,617 NeoGenomics shares in Q1 2022, an estimated $11.5M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in NeoGenomics in Q1 2021 and held it in 4 quarters.
  • Lombard Odier Asset Management (Switzerland)'s NeoGenomics position peaked at $28.2M in Q3 2021.
  • 280 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 16 May 2022.